Trials / Conditions / Post-transplant Lymphoproliferative Disease
Post-transplant Lymphoproliferative Disease
3 registered clinical trials studyying Post-transplant Lymphoproliferative Disease.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant NCT03131934 | University College, London | EARLY_Phase 1 |
| Completed | Bortezomib Plus Rituximab for EBV+ PTLD NCT01058239 | Massachusetts General Hospital | Phase 2 |
| Terminated | Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma NCT01964755 | University of Miami | Phase 2 |